Alder BioPharmaceuticals Announces Commencement Of Public Offerin
BOTHELL, Wash., April 06, 2016 (GLOBE NEWSWIRE) — Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR) , a clinical-stage biopharmaceutical company, announced today that it intends to offer and sell, subject to market and other conditions, $100 million of its common stock in an underwritten public offering. In connection with this offering, Alder expects to grant the underwriters a…